Advanced Search

 

Study ID Status Title Patient Level Data
101892 Completed A 12-Week, Double-Blind, Placebo-Controlled, Parallel-Group Study To Assess The Effectiveness Of Ropinirole In Patients Willing To Take Regular Medication For Their Restless Legs Syndrome In A Primary Care Setting
101909 Completed A single blind, randomised, placebo controlled, single ascending dose study to evaluate the safety, tolerability and pharmacokinetics of GSK206136 in healthy male subjects and an open label Positron Emission Tomography study to evaluate the serotonin transporter and neurokinin-1 receptor occupancy
101963 Completed A randomised, blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and risperidone in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
101969 Completed Title A Study to Evaluate the Effect of Repeated Oral Doses of WELLBUTRIN XL Compared with Placebo and Single Oral Doses of Moxifloxacin on Cardiac Conduction as assessed by 12-lead Electrocardiogram
101998 Completed A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Study Listed on ClinicalStudyDataRequest.com
101999 Completed A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Study Listed on ClinicalStudyDataRequest.com
102027 Completed Expanded access program for fosamprenavir (FPV, GW433908) in HIV infected subjects not responding or intolerant to the previous antiretroviral treatments.
102038 Completed Open, phase IV clinical trial to compare the immunogenicity and reactogenicity of GSK Biologicals’ Infanrix™ (DTPa) vaccine administered as a booster dose at 4 years of age in preterm vs. full-term children previously primed and boosted with Infanrix™ hexa.
102094 Completed A single-administration, dose response study of Salmeterol xinafoate in pediatric bronchial asthma
102095 Completed Clinical assessment of inhaled salmeterol xinafoate Diskus [SN408D] in subjects with pediatric bronchial asthma - Assessment of efficacy and safety of the regimen at 50mcg twice daily in an open-label study-
102114 Completed A double-blind, controlled, randomised, phase I dose-range study to assess the safety and imunogenicity of an HPV-VLP vaccine against Human Papillomavirus Types 31 and 45 evaluated in Healthy Adult Female Volunteers in a 0, 1, 6 months schedule
102115 Completed A dose-range study to assess the safety and immunogenicity of a novel HPV vaccine when administered intramuscularly according to a 3-dose schedule (0,1,6-month) in healthy adult females (18-25 years of age) Study Listed on ClinicalStudyDataRequest.com
102123 Completed A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Study Listed on ClinicalStudyDataRequest.com
102130 Completed An open-label, randomized, four-period crossover study in healthy subjects to demonstrate the bioequivalence of a fixed dose combination tablet formulation of rosiglitazone/simvastatin (8mg/80mg) to concomitant dosing of rosiglitazone 8mg and simvastatin 80mg commercial tablets and to assess the pharmacokinetics of the concomitant dosing of rosiglitazone 8mg and simvastatin 80mg commercial tablets relative to commercial rosiglitazone 8mg alone, and commercial simvastatin 80mg alone, in healthy subjects Study Listed on ClinicalStudyDataRequest.com
102144 Completed Study to assess immunogenicity and reactogenicity of a booster dose of GSK Biologicals Kft’s combined DTPwCSL-HB vaccine as compared to concomitant administration of CSL’s DTPw vaccine and GSK Biologicals' hepatitis B vaccine at separate injection sites and to GSK Biologicals' DTPw-HB vaccine Study Listed on ClinicalStudyDataRequest.com
102146 Completed An open-label, randomized, three-period crossover study to demonstrate the bioequivalence of sumatriptan 4 mg STATdose to IMITREX™ 6 mg STATdose after dose-normalization, and to assess the relative bioavailability of 4 mg sumatriptan injected using the STATdose device compared to 4 mg sumatripta ... Study Listed on ClinicalStudyDataRequest.com
102151 Completed Open immunization study to determine the reactogenicity and immunogenicity of Fluarix™/Influsplit SSW® 2004/2005 in persons as of 18 years of age.
102238 Completed A multicenter, open-label Phase I/II trial to evaluate the safety and activity of CPC-P501 protein formulated with the adjuvant AS15 as first-line treatment in patients with hormone-sensitive prostate cancer who show rising PSA
102247/036 Completed A multi-country & multi-center study to assess the efficacy, safety & immunogenicity of 2 doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants in co-administration with specific childhood vaccines Study Listed on ClinicalStudyDataRequest.com
102247/036 Annex Completed A phase IIIb, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy, safety and immunogenicity of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants in co-administration with specific childhood vaccines
102248 Completed Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Study Listed on ClinicalStudyDataRequest.com
102318 Completed Steroid-sparing management of the salmeterol/fluticasone 50/100µg b.i.d. combination compared to fluticasone 200µg b.i.d. in children and adolescents with moderate asthma
102370 (primary study) Completed A multicentre primary & booster vaccination study of GSK Biologicals' Hib-MenCY-TT conjugate vaccine vs ActHIB® & MenC conjugate licensed vaccine when given according to the 2-4-6 month schedule to healthy infants with booster dose at 12 to 15 months Study Listed on ClinicalStudyDataRequest.com
102394 Completed A Phase IV, partially double-blind study to demonstrate non-inferiority of GSK Biologicals’ Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process) when administered as a single dose to subjects aged 2-30 yrs Study Listed on ClinicalStudyDataRequest.com
102396/002 Completed Study in order to evaluate reactogenicity and immunogenicity of GlaxoSmithKline Biologicals' experimental influenza vaccine in an elderly population aged over 65 years (>= 65 years-old) and previously vaccinated in 2003 with the experimental influenza vaccine in the Explo-Flu-001 clinical trial

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.